Brachytherapy With Durvalumab or Tremelimumab for the Treatment of Patients With Platinum-Resistant, Refractory, Recurrent, or Metastatic Gynecological Malignancies

Name: Brachytherapy With Durvalumab or Tremelimumab for the Treatment of Patients With Platinum-Resistant, Refractory, Recurrent, or Metastatic Gynecological Malignancies
License: Public Domain

Jonsson Comprehensive Cancer Center

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

metastatic malignant female reproductive system neoplasm, platinum-resistant malignant female reproductive system neoplasm, recurrent malignant female reproductive system neoplasm, refractory malignant female reproductive system neoplasm

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 623512
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.